The SeroELISA™ Chlamydia product line is intended for the determination of IgG, IgA and IgM antibodies to Chlamydia in human serum by an Enzyme-Linked Immunosorbent Asssay (ELISA).

The SeroELISA™ Chlamydia test employs the L2 serovar broadly reacting antigen of C. trachomatis. It will detect C. trachomatis, C. psittaci and C. pneumoniae (TWAR) antibodies. Due to the SeroELISA™ pre-calibrated components and assay procedure, the absorbance at 450nm is indicative of IgG, IgA and IgM titer in patient serum specimens.

The SeroELISA™ Chlamydia product line is ideal for high and low volume laboratories

Catalog No Product name Tests/kit Approvals
A111-01 SeroELISA Chlamydia IgG 96 CE 0483/FDA
A112-01 SeroELISA Chlamydia TRUE-IgM 96 CE 0483
A113-01 SeroELISA Chlamydia IgA 96 CE0483/FDA